LIPOSOMA develops and manufactures advanced lipid-based formulations, including liposomes and lipid nanoparticles, for research, food, and pharmaceutical applications. These delivery systems are designed to enhance bioavailability, improve stability, enable targeted delivery, and reduce toxicity of active ingredients.
We support our partners with custom development, scalable manufacturing, and full analytical control, delivering high-performance solutions for complex active ingredients. Available as branded or white-label products.
At LIPOSOMA Nutrateq, we specialize in lipid-based technologies that enhance the formulation, protection, and delivery of natural active ingredients in oral products for consumer health.
At LIPOSOMA, we specialize in the development and production of advanced liposomal supplements and fortified food ingredients. Our premium-quality nutraceuticals are backed by the scientific expertise of our academically trained team and a steadfast commitment to research excellence.
LIPOSOMA clodronate liposomes is the pioneering company behind the invention of clodronate liposomes, a groundbreaking technology designed by Nico van Rooijen, to target and deplete specific immune cells.
We have more than 40 years of experience in developing liposomal formulations and applications
We integrate knowledge of well known liposome academics into our liposome technology
Our customers include some of the most prominent academic & private research institutes worldwide
At LIPOSOMA we build on decades of expertise to deliver distinctive and high-quality liposomal formulations. Our scientific staff includes key opinion leaders in lipid-based delivery technologies. We work for the most prominent academic and private research institutes, pharmaceutical companies, distributors and manufacturers worldwide.
INNOVATION IS OUR FOCUS
We invest an overwhelming share of our revenues in Research & Development, ranging from immunological and pharmaceutical research to medical nutrition.